People · Operator
Named in public records as an officer, director or promoter · active 2006–2018 · Other, Other Technology, Other Health Care, Pharmaceuticals, Retailing
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Honest Company, Inc. | — | Other | Series C | $289.8M | $1.2B | 2013 |
| eCullet Inc | — | Other Technology | Series B | $41.4M | $70.0M | 2012 |
| Goldcup 12446 AB | — | Other Health Care | Series B | $29.7M | $657.1M | 2016 |
| DeTech Acquisition Co. | — | Other | Series B | $20.6M | $341.7M | 2018 |
| Vitriflex, Inc. | — | Other Technology | Series A | $20.5M | $224.7M | 2011 |
| Victory Pharma Inc | — | Pharmaceuticals | Series A | $10.0M | $309.7M | 2009 |
| CarGurus, Inc. | — | Retailing | Seed | $3.1M | $8.8M | 2006 |
| Blue Frog Gaming Inc | — | Other Technology | Seed | $1.2M | $42.6M | 2010 |
| Coffee Applications Inc. | — | Other Technology | Pre-Seed | $549K | $23.3M | 2014 |
| ANKAA Corp. | — | Other | Pre-Seed | $305K | $7.0M | 2011 |
| Tippt Media, Inc. | — | Other Technology | Pre-Seed | $100K | $4.2M | 2013 |
David Parker at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Parker on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Herbert Hooper | 2 | 3 |
| Langley Steinert | 2 | 2 |
| Brian Lee | 1 | 19 |
| Jeremy Liew | 1 | 18 |
| Joel Cutler | 1 | 16 |
| Arman Pahlavan | 1 | 12 |
| Youngme Moon | 1 | 6 |
| Anastasios Parafestas | 1 | 5 |
| Neil Sequeria | 1 | 5 |
| David Snyder | 1 | 5 |
| Eric Liaw | 1 | 5 |
| David Pearce | 1 | 5 |
| Scott Barry | 1 | 4 |
| Ian Smith | 1 | 4 |
| Marc Adelman | 1 | 4 |
| Simon Rothman | 1 | 4 |
| Greg Stanger | 1 | 4 |
| Marc Khouzami | 1 | 3 |
| Quaeed Motiwala | 1 | 3 |
| Thomas Wiggans | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.